Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.91
BATS BZX Real-Time Price
As of 11:53am ET
 -0.055 / -0.79%
Today’s Change
4.60
Today|||52-Week Range
8.63
+16.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line4.4M-39.1M10.7M-51.0M
 
 
 
 
 
Depreciation545.0K565.0K2.1M1.1M
 
 
 
 
 
Total Other Cash Flow7.6M4.5M-1.6M7.0M
 
 
 
 
 
Funds From Operations11.6M-34.1M13.0M-54.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.2M6.0M-6.2M-713.0K
 
 
 
 
 
Net Cash Flow - Operating Activities13.7M-40.1M19.2M-53.6M
 
 
 
 
 
 
InvestingDecrease In Investments2.4M0.000.000.00
 
 
Capital Expenditures-714.0K-370.0K-4.3M-269.0K
 
 
 
 
 
Fixed Asset Disposal143.0K48.0K347.0K52.0K
 
 
 
 
 
Net Assets From Acquisitions 0.00-6.5M-368.0K0.00
 
 
 
Net Cash Flow Investing1.8M-6.8M-4.3M-217.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.0048.7M0.00
 
 
Long Term Debt Reduction0.000.00--0.00--
Net Proceeds Stock Sale37.9M1.7M1.3M5.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing37.9M1.7M50.0M5.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.0017.0K-86.0K83.0K
 
 
 
 
 
Net Change In Cash53.4M-45.2M64.9M-48.4M